The human gut microbiome has gained increasing attention over the past two decades.Several findings have shown that this complex and dynamic microbial ecosystem can contribute to the maintenance of host health or,when...The human gut microbiome has gained increasing attention over the past two decades.Several findings have shown that this complex and dynamic microbial ecosystem can contribute to the maintenance of host health or,when subject to imbalances,to the pathogenesis of various enteric and non-enteric diseases.This scoping review summarizes the current knowledge on how the gut microbiota and microbially-derived compounds affect host metabolism,especially in the context of obesity and related disorders.Examples of microbiome-based targeted intervention strategies that aim to restore and maintain an eubiotic layout are then discussed.Adjuvant therapeutic interventions to alleviate obesity and associated comorbidities are traditionally based on diet modulation and the supplementation of prebiotics,probiotics and synbiotics.However,these approaches have shown only moderate ability to induce sustained changes in the gut microbial ecosystem,making the development of innovative and tailored microbiome-based intervention strategies of utmost importance in clinical practice.In this regard,the administration of next-generation probiotics and engineered microbiomes has shown promising results,together with more radical intervention strategies based on the replacement of the dysbiotic ecosystem by means of fecal microbiota transplantation from healthy donors or with the introduction of synthetic communities specifically designed to achieve the desired therapeutic outcome.Finally,we provide a perspective for future translational investigations through the implementation of bioinformatics approaches,including machine and deep learning,to predict health risks and therapeutic outcomes.展开更多
文摘The human gut microbiome has gained increasing attention over the past two decades.Several findings have shown that this complex and dynamic microbial ecosystem can contribute to the maintenance of host health or,when subject to imbalances,to the pathogenesis of various enteric and non-enteric diseases.This scoping review summarizes the current knowledge on how the gut microbiota and microbially-derived compounds affect host metabolism,especially in the context of obesity and related disorders.Examples of microbiome-based targeted intervention strategies that aim to restore and maintain an eubiotic layout are then discussed.Adjuvant therapeutic interventions to alleviate obesity and associated comorbidities are traditionally based on diet modulation and the supplementation of prebiotics,probiotics and synbiotics.However,these approaches have shown only moderate ability to induce sustained changes in the gut microbial ecosystem,making the development of innovative and tailored microbiome-based intervention strategies of utmost importance in clinical practice.In this regard,the administration of next-generation probiotics and engineered microbiomes has shown promising results,together with more radical intervention strategies based on the replacement of the dysbiotic ecosystem by means of fecal microbiota transplantation from healthy donors or with the introduction of synthetic communities specifically designed to achieve the desired therapeutic outcome.Finally,we provide a perspective for future translational investigations through the implementation of bioinformatics approaches,including machine and deep learning,to predict health risks and therapeutic outcomes.
